Truscreen Group Ltd NZX:TRU:
FY 31 MARCH 2026 REVENUE AND RESULTS GUIDANCE ACHIEVED
TOTAL UNAUDITED REVENUE FOR FY2026 IS EXPECTED TO BE NZ$2.8 MILLION
FY2026 UNAUDITED LOSS EXPECTED AT ABOUT NZ$2.2 MILLION
Truscreen Group Sees FY26 Unaudited Loss
Story so far
Earlier from TruScreen
- Truscreen Says Submits Three Proposals To Unitaid's Global Cervical Cancer Elimination Call
- Truscreen Group Sees Total Revenue For Fy2026 To Be Nz$2.7 Million
- Truscreen Group Provides Management Update
- TruScreen Validated as Superior Cervical Cancer Screening Tool in Major Chinese Study
- Truscreen Group Says It Signed First Uzbekistan Sales Contract
Later from TruScreen
- TRU: AI-driven cervical cancer screening device posts rapid sales growth and global expansion
- TRU: FY26 sales up 42% YOY, global expansion accelerates, and FY27 outlook remains robust
- Truscreen Group Says Tony Ho To Resume Role As Independent Non-Executive Chairman
Follow TruScreen into a list and get an email when it puts out news.
Follow TruScreen